Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy, Surgery, and Stem Cell Transplant in Metastatic Neuroblastoma
NCT00024193Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Apr 1999
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide, doxorubicin, vincristine, cisplatin, etoposide and 2 more in neuroblastoma, sponsored by Children's Cancer and Leukaemia Group. Primary endpoints: Efficacy of induction chemotherapy followed by surgical resection and consolidation chemotherapy with autologous PBSC transplantation and Tolerability and feasibility of the regimen. Status: unknown.
02
Drugs
cyclophosphamidedoxorubicinvincristinecisplatinetoposide
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00024193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024193.